Redmile Group, LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Redmile Group, LLC disclosed 63 US equity positions worth $1.7bn in its Q3 2024 13F filing. The largest position was KRYS at 8.7% of the reported book, followed by NRIX and AM6.
What did Redmile Group, LLC own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | KRYS KRYSTAL BIOTECH INC | Healthcare | 8.7% | $147.5m | 810,245 | – | |
| 2 | NRIX NURIX THERAPEUTICS INC | Healthcare | 5.7% | $96.2m | 4,280,981 | – | |
| 3 | AM6 AMICUS THERAPEUTICS INC | 5.2% | $88.1m | 8,246,592 | – | ||
| 4 | IMNM IMMUNOME INC | Healthcare | 4.2% | $71.5m | 4,889,554 | – | |
| 5 | KYMR KYMERA THERAPEUTICS INC | Healthcare | 3.9% | $65.9m | 1,393,256 | – | |
| 6 | ZYME ZYMEWORKS INC | Healthcare | 3.8% | $64.0m | 5,101,911 | – | |
| 7 | STOK STOKE THERAPEUTICS INC | Healthcare | 3.4% | $57.9m | 4,713,509 | – | |
| 8 | REPL REPLIMUNE GROUP INC | Healthcare | 3.1% | $52.4m | 4,781,183 | – | |
| 9 | BHVN BIOHAVEN LTD | Healthcare | 3.0% | $51.7m | 1,034,219 | – | |
| 10 | RGNX REGENXBIO INC | Healthcare | 3.0% | $51.3m | 4,892,902 | – | |
| 11 | 1K0 IGM BIOSCIENCES INC | 3.0% | $50.8m | 3,072,478 | – | ||
| 12 | ADCT ADC THERAPEUTICS SA | Healthcare | 2.9% | $49.4m | 15,669,217 | – | |
| 13 | COGT COGENT BIOSCIENCES INC | Healthcare | 2.9% | $48.4m | 4,484,380 | – | |
| 14 | FATE FATE THERAPEUTICS INC | Healthcare | 2.7% | $46.1m | 13,169,057 | – | |
| 15 | LIVN LIVANOVA PLC | Healthcare | 2.7% | $46.0m | 875,039 | – | |
| 16 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 2.5% | $42.0m | 5,238,837 | – | |
| 17 | NGNE NEUROGENE INC | 2.4% | $40.5m | 964,347 | – | ||
| 18 | AKERO THERAPEUTICS INC | 2.3% | $39.8m | 1,387,479 | – | ||
| 19 | BEAM BEAM THERAPEUTICS INC | Healthcare | 2.3% | $39.5m | 1,611,013 | – | |
| 20 | AUGX AUGMEDIX INC | 2.3% | $38.5m | 16,380,327 | – | ||
| 21 | ANNX ANNEXON INC | Healthcare | 2.2% | $38.1m | 6,427,462 | – | |
| 22 | CTLTEUR CATALENT INC | 2.1% | $36.1m | 595,570 | – | ||
| 23 | PLRX PLIANT THERAPEUTICS INC | Healthcare | 2.1% | $35.8m | 3,197,491 | – | |
| 24 | SLN SILENCE THERAPEUTICS PLC | 2.0% | $34.5m | 1,899,317 | – | ||
| 25 | KROS KEROS THERAPEUTICS INC | Healthcare | 1.9% | $32.1m | 552,506 | – | |
| 26 | ABSI ABSCI CORPORATION | 1.9% | $31.5m | 8,253,316 | – | ||
| 27 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 1.6% | $27.7m | 330,873 | – | |
| 28 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 1.3% | $22.3m | 657,175 | – | |
| 29 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 1.3% | $21.6m | 681,150 | – | |
| 30 | STTK SHATTUCK LABS INC | Healthcare | 1.2% | $19.6m | 5,615,489 | – | |
| 31 | BNTX BIONTECH SE | Healthcare | 1.1% | $18.3m | 154,456 | – | |
| 32 | IMVT IMMUNOVANT INC | Healthcare | 1.1% | $18.3m | 642,229 | – | |
| 33 | FDMT 4D MOLECULAR THERAPEUTICS IN | 0.8% | $13.6m | 1,262,090 | – | ||
| 34 | ISRG INTUITIVE SURGICAL INC | Healthcare | 0.8% | $13.1m | 26,698 | – | |
| 35 | SYK STRYKER CORPORATION | Healthcare | 0.7% | $11.8m | 32,741 | – | |
| 36 | ETNBGBP 89BIO INC | 0.7% | $11.6m | 1,569,850 | – | ||
| 37 | ARDX ARDELYX INC | Healthcare | 0.7% | $11.4m | 1,660,763 | – | |
| 38 | ESTA ESTABLISHMENT LABS HLDGS INC | Healthcare | 0.7% | $11.3m | 261,803 | – | |
| 39 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 0.6% | $10.1m | 411,728 | – | |
| 40 | PRME PRIME MEDICINE INC | 0.5% | $8.0m | 2,074,350 | – | ||
| 41 | ALXO ALX ONCOLOGY HLDGS INC | Healthcare | 0.4% | $7.0m | 3,836,576 | – | |
| 42 | NUVB NUVATION BIO INC | Healthcare | 0.4% | $6.9m | 3,031,009 | – | |
| 43 | VERVE THERAPEUTICS INC | 0.4% | $6.7m | 1,383,366 | – | ||
| 44 | RPTX REPARE THERAPEUTICS INC | 0.4% | $6.7m | 1,942,555 | – | ||
| 45 | ACIU AC IMMUNE SA | Healthcare | 0.4% | $6.4m | 1,694,167 | – | |
| 46 | CYTK CYTOKINETICS INC | Healthcare | 0.3% | $5.1m | 97,116 | – | |
| 47 | VTYXUSD VENTYX BIOSCIENCES INC | 0.3% | $4.6m | 2,107,215 | – | ||
| 48 | STXS STEREOTAXIS INC | 0.3% | $4.3m | 2,108,219 | – | ||
| 49 | ATRA ATARA BIOTHERAPEUTICS INC | 0.2% | $3.7m | 452,270 | – | ||
| 50 | BOLD BOUNDLESS BIO INC | 0.2% | $3.6m | 1,023,548 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.